nodes	percent_of_prediction	percent_of_DWPC	metapath
Pergolide—HTR2A—phrenic nerve—amyotrophic lateral sclerosis	0.0232	0.105	CbGeAlD
Pergolide—Carcinoma of lung—Riluzole—amyotrophic lateral sclerosis	0.0204	0.0265	CcSEcCtD
Pergolide—Lung neoplasm malignant—Riluzole—amyotrophic lateral sclerosis	0.0177	0.0229	CcSEcCtD
Pergolide—Iron deficiency anaemia—Riluzole—amyotrophic lateral sclerosis	0.0156	0.0202	CcSEcCtD
Pergolide—Salivary gland enlargement—Riluzole—amyotrophic lateral sclerosis	0.0128	0.0166	CcSEcCtD
Pergolide—Skin nodule—Riluzole—amyotrophic lateral sclerosis	0.0128	0.0166	CcSEcCtD
Pergolide—HTR1B—cranial nerve—amyotrophic lateral sclerosis	0.0126	0.0567	CbGeAlD
Pergolide—HTR1D—cranial nerve—amyotrophic lateral sclerosis	0.0122	0.0549	CbGeAlD
Pergolide—Skin mass—Riluzole—amyotrophic lateral sclerosis	0.0114	0.0148	CcSEcCtD
Pergolide—Facial paralysis—Riluzole—amyotrophic lateral sclerosis	0.0111	0.0145	CcSEcCtD
Pergolide—Uterine haemorrhage—Riluzole—amyotrophic lateral sclerosis	0.0101	0.0132	CcSEcCtD
Pergolide—Hemiplegia—Riluzole—amyotrophic lateral sclerosis	0.00992	0.0129	CcSEcCtD
Pergolide—Dental caries—Riluzole—amyotrophic lateral sclerosis	0.00951	0.0123	CcSEcCtD
Pergolide—Hypoventilation—Riluzole—amyotrophic lateral sclerosis	0.00951	0.0123	CcSEcCtD
Pergolide—Pyelonephritis—Riluzole—amyotrophic lateral sclerosis	0.00932	0.0121	CcSEcCtD
Pergolide—Manic psychosis—Riluzole—amyotrophic lateral sclerosis	0.00896	0.0116	CcSEcCtD
Pergolide—VIIth nerve paralysis—Riluzole—amyotrophic lateral sclerosis	0.00864	0.0112	CcSEcCtD
Pergolide—Fungal skin infection—Riluzole—amyotrophic lateral sclerosis	0.00848	0.011	CcSEcCtD
Pergolide—Paranoid reaction—Riluzole—amyotrophic lateral sclerosis	0.00834	0.0108	CcSEcCtD
Pergolide—Personality disorder—Riluzole—amyotrophic lateral sclerosis	0.00819	0.0106	CcSEcCtD
Pergolide—Pericarditis—Riluzole—amyotrophic lateral sclerosis	0.00819	0.0106	CcSEcCtD
Pergolide—DRD1—nerve—amyotrophic lateral sclerosis	0.00795	0.0358	CbGeAlD
Pergolide—Hernia—Riluzole—amyotrophic lateral sclerosis	0.00756	0.0098	CcSEcCtD
Pergolide—Cerebral ischaemia—Riluzole—amyotrophic lateral sclerosis	0.00733	0.00951	CcSEcCtD
Pergolide—Priapism—Riluzole—amyotrophic lateral sclerosis	0.00733	0.00951	CcSEcCtD
Pergolide—Pneumothorax—Riluzole—amyotrophic lateral sclerosis	0.00712	0.00924	CcSEcCtD
Pergolide—Muscle relaxant therapy—Riluzole—amyotrophic lateral sclerosis	0.00712	0.00924	CcSEcCtD
Pergolide—Faecal incontinence—Riluzole—amyotrophic lateral sclerosis	0.00702	0.00911	CcSEcCtD
Pergolide—Hypotonia—Riluzole—amyotrophic lateral sclerosis	0.00674	0.00874	CcSEcCtD
Pergolide—Cerebral haemorrhage—Riluzole—amyotrophic lateral sclerosis	0.0064	0.0083	CcSEcCtD
Pergolide—Hostility—Riluzole—amyotrophic lateral sclerosis	0.0064	0.0083	CcSEcCtD
Pergolide—Osteoporosis—Riluzole—amyotrophic lateral sclerosis	0.00632	0.0082	CcSEcCtD
Pergolide—Body temperature decreased—Riluzole—amyotrophic lateral sclerosis	0.00632	0.0082	CcSEcCtD
Pergolide—Hypothermia—Riluzole—amyotrophic lateral sclerosis	0.00632	0.0082	CcSEcCtD
Pergolide—Cholecystitis—Riluzole—amyotrophic lateral sclerosis	0.00617	0.008	CcSEcCtD
Pergolide—Gastric ulcer—Riluzole—amyotrophic lateral sclerosis	0.0061	0.00791	CcSEcCtD
Pergolide—HTR2A—cranial nerve—amyotrophic lateral sclerosis	0.00604	0.0273	CbGeAlD
Pergolide—HTR2A—pons—amyotrophic lateral sclerosis	0.00597	0.0269	CbGeAlD
Pergolide—Myoclonus—Riluzole—amyotrophic lateral sclerosis	0.00589	0.00764	CcSEcCtD
Pergolide—Enlargement abdomen—Riluzole—amyotrophic lateral sclerosis	0.00589	0.00764	CcSEcCtD
Pergolide—Libido increased—Riluzole—amyotrophic lateral sclerosis	0.00582	0.00755	CcSEcCtD
Pergolide—Hypoxia—Riluzole—amyotrophic lateral sclerosis	0.00558	0.00723	CcSEcCtD
Pergolide—Calculus of kidney—Riluzole—amyotrophic lateral sclerosis	0.00541	0.00701	CcSEcCtD
Pergolide—Hypokinesia—Riluzole—amyotrophic lateral sclerosis	0.00525	0.00681	CcSEcCtD
Pergolide—Intestinal obstruction—Riluzole—amyotrophic lateral sclerosis	0.0052	0.00674	CcSEcCtD
Pergolide—Paranoia—Riluzole—amyotrophic lateral sclerosis	0.0052	0.00674	CcSEcCtD
Pergolide—Seborrhoeic dermatitis—Riluzole—amyotrophic lateral sclerosis	0.0052	0.00674	CcSEcCtD
Pergolide—Hyperventilation—Riluzole—amyotrophic lateral sclerosis	0.00515	0.00668	CcSEcCtD
Pergolide—Haematemesis—Riluzole—amyotrophic lateral sclerosis	0.0051	0.00661	CcSEcCtD
Pergolide—HTR2A—hindlimb—amyotrophic lateral sclerosis	0.00509	0.023	CbGeAlD
Pergolide—Cyanosis—Riluzole—amyotrophic lateral sclerosis	0.00501	0.00649	CcSEcCtD
Pergolide—Delusion—Riluzole—amyotrophic lateral sclerosis	0.00501	0.00649	CcSEcCtD
Pergolide—Metrorrhagia—Riluzole—amyotrophic lateral sclerosis	0.00496	0.00643	CcSEcCtD
Pergolide—Apathy—Riluzole—amyotrophic lateral sclerosis	0.00496	0.00643	CcSEcCtD
Pergolide—Laryngitis—Riluzole—amyotrophic lateral sclerosis	0.00492	0.00638	CcSEcCtD
Pergolide—Flat affect—Riluzole—amyotrophic lateral sclerosis	0.00492	0.00638	CcSEcCtD
Pergolide—Mania—Riluzole—amyotrophic lateral sclerosis	0.00487	0.00632	CcSEcCtD
Pergolide—Haemoptysis—Riluzole—amyotrophic lateral sclerosis	0.00479	0.00621	CcSEcCtD
Pergolide—Stupor—Riluzole—amyotrophic lateral sclerosis	0.00475	0.00615	CcSEcCtD
Pergolide—Neuritis—Riluzole—amyotrophic lateral sclerosis	0.00475	0.00615	CcSEcCtD
Pergolide—Extrapyramidal disorder—Riluzole—amyotrophic lateral sclerosis	0.00471	0.0061	CcSEcCtD
Pergolide—Glaucoma—Riluzole—amyotrophic lateral sclerosis	0.00471	0.0061	CcSEcCtD
Pergolide—DRD2—nerve—amyotrophic lateral sclerosis	0.0047	0.0212	CbGeAlD
Pergolide—ADRA2A—peripheral nervous system—amyotrophic lateral sclerosis	0.00467	0.0211	CbGeAlD
Pergolide—Pleural effusion—Riluzole—amyotrophic lateral sclerosis	0.00463	0.006	CcSEcCtD
Pergolide—Skin ulcer—Riluzole—amyotrophic lateral sclerosis	0.00455	0.0059	CcSEcCtD
Pergolide—Abscess—Riluzole—amyotrophic lateral sclerosis	0.00448	0.00581	CcSEcCtD
Pergolide—Nephrolithiasis—Riluzole—amyotrophic lateral sclerosis	0.00441	0.00572	CcSEcCtD
Pergolide—HTR2A—appendage—amyotrophic lateral sclerosis	0.00437	0.0197	CbGeAlD
Pergolide—Petechiae—Riluzole—amyotrophic lateral sclerosis	0.00431	0.00559	CcSEcCtD
Pergolide—Endocrine disorder—Riluzole—amyotrophic lateral sclerosis	0.00427	0.00554	CcSEcCtD
Pergolide—Apnoea—Riluzole—amyotrophic lateral sclerosis	0.00418	0.00542	CcSEcCtD
Pergolide—Delirium—Riluzole—amyotrophic lateral sclerosis	0.00412	0.00534	CcSEcCtD
Pergolide—Breast pain—Riluzole—amyotrophic lateral sclerosis	0.00406	0.00527	CcSEcCtD
Pergolide—Amenorrhoea—Riluzole—amyotrophic lateral sclerosis	0.00403	0.00523	CcSEcCtD
Pergolide—Accidental injury—Riluzole—amyotrophic lateral sclerosis	0.004	0.00519	CcSEcCtD
Pergolide—HTR2A—peripheral nervous system—amyotrophic lateral sclerosis	0.00397	0.0179	CbGeAlD
Pergolide—Ventricular extrasystoles—Riluzole—amyotrophic lateral sclerosis	0.00392	0.00509	CcSEcCtD
Pergolide—Cellulitis—Riluzole—amyotrophic lateral sclerosis	0.0039	0.00505	CcSEcCtD
Pergolide—HTR1A—hindbrain—amyotrophic lateral sclerosis	0.00389	0.0176	CbGeAlD
Pergolide—Thinking abnormal—Riluzole—amyotrophic lateral sclerosis	0.00387	0.00502	CcSEcCtD
Pergolide—Cough increased—Riluzole—amyotrophic lateral sclerosis	0.00387	0.00502	CcSEcCtD
Pergolide—Glossitis—Riluzole—amyotrophic lateral sclerosis	0.00385	0.00499	CcSEcCtD
Pergolide—Gout—Riluzole—amyotrophic lateral sclerosis	0.0038	0.00492	CcSEcCtD
Pergolide—Leukocytosis—Riluzole—amyotrophic lateral sclerosis	0.00377	0.00489	CcSEcCtD
Pergolide—Hypercholesterolaemia—Riluzole—amyotrophic lateral sclerosis	0.00375	0.00486	CcSEcCtD
Pergolide—Cataract—Riluzole—amyotrophic lateral sclerosis	0.00372	0.00483	CcSEcCtD
Pergolide—Gait disturbance—Riluzole—amyotrophic lateral sclerosis	0.00363	0.00471	CcSEcCtD
Pergolide—Coordination abnormal—Riluzole—amyotrophic lateral sclerosis	0.00361	0.00468	CcSEcCtD
Pergolide—Respiratory failure—Riluzole—amyotrophic lateral sclerosis	0.00361	0.00468	CcSEcCtD
Pergolide—ADRA1A—hindbrain—amyotrophic lateral sclerosis	0.00359	0.0162	CbGeAlD
Pergolide—Neck pain—Riluzole—amyotrophic lateral sclerosis	0.00359	0.00465	CcSEcCtD
Pergolide—Ventricular tachycardia—Riluzole—amyotrophic lateral sclerosis	0.00354	0.0046	CcSEcCtD
Pergolide—Hiccups—Riluzole—amyotrophic lateral sclerosis	0.00354	0.0046	CcSEcCtD
Pergolide—Pulmonary embolism—Riluzole—amyotrophic lateral sclerosis	0.00354	0.0046	CcSEcCtD
Pergolide—DRD2—hindbrain—amyotrophic lateral sclerosis	0.00352	0.0159	CbGeAlD
Pergolide—Abnormal dreams—Riluzole—amyotrophic lateral sclerosis	0.0035	0.00454	CcSEcCtD
Pergolide—Melaena—Riluzole—amyotrophic lateral sclerosis	0.00346	0.00449	CcSEcCtD
Pergolide—Depressed level of consciousness—Riluzole—amyotrophic lateral sclerosis	0.00342	0.00444	CcSEcCtD
Pergolide—Urinary incontinence—Riluzole—amyotrophic lateral sclerosis	0.00342	0.00444	CcSEcCtD
Pergolide—DRD1—brainstem—amyotrophic lateral sclerosis	0.00341	0.0154	CbGeAlD
Pergolide—Candida infection—Riluzole—amyotrophic lateral sclerosis	0.00338	0.00439	CcSEcCtD
Pergolide—Photophobia—Riluzole—amyotrophic lateral sclerosis	0.00333	0.00431	CcSEcCtD
Pergolide—Coma—Riluzole—amyotrophic lateral sclerosis	0.00324	0.0042	CcSEcCtD
Pergolide—Neoplasm—Riluzole—amyotrophic lateral sclerosis	0.0032	0.00415	CcSEcCtD
Pergolide—Pulmonary oedema—Riluzole—amyotrophic lateral sclerosis	0.00315	0.00409	CcSEcCtD
Pergolide—Hypertonia—Riluzole—amyotrophic lateral sclerosis	0.00311	0.00403	CcSEcCtD
Pergolide—HTR2A—nerve—amyotrophic lateral sclerosis	0.0031	0.014	CbGeAlD
Pergolide—Mental disability—Riluzole—amyotrophic lateral sclerosis	0.00307	0.00399	CcSEcCtD
Pergolide—Sepsis—Riluzole—amyotrophic lateral sclerosis	0.00307	0.00399	CcSEcCtD
Pergolide—Euphoric mood—Riluzole—amyotrophic lateral sclerosis	0.00304	0.00395	CcSEcCtD
Pergolide—Ear pain—Riluzole—amyotrophic lateral sclerosis	0.00301	0.00391	CcSEcCtD
Pergolide—Lymphadenopathy—Riluzole—amyotrophic lateral sclerosis	0.00301	0.00391	CcSEcCtD
Pergolide—Diabetes mellitus—Riluzole—amyotrophic lateral sclerosis	0.00296	0.00383	CcSEcCtD
Pergolide—Vascular purpura—Riluzole—amyotrophic lateral sclerosis	0.00288	0.00373	CcSEcCtD
Pergolide—Deafness—Riluzole—amyotrophic lateral sclerosis	0.00288	0.00373	CcSEcCtD
Pergolide—Eczema—Riluzole—amyotrophic lateral sclerosis	0.00286	0.00371	CcSEcCtD
Pergolide—Cardiac failure congestive—Riluzole—amyotrophic lateral sclerosis	0.00284	0.00368	CcSEcCtD
Pergolide—Injury—Riluzole—amyotrophic lateral sclerosis	0.0028	0.00363	CcSEcCtD
Pergolide—Libido decreased—Riluzole—amyotrophic lateral sclerosis	0.00277	0.0036	CcSEcCtD
Pergolide—HTR1B—brainstem—amyotrophic lateral sclerosis	0.00276	0.0125	CbGeAlD
Pergolide—Increased appetite—Riluzole—amyotrophic lateral sclerosis	0.00274	0.00355	CcSEcCtD
Pergolide—Amnesia—Riluzole—amyotrophic lateral sclerosis	0.00274	0.00355	CcSEcCtD
Pergolide—DRD4—brain—amyotrophic lateral sclerosis	0.00271	0.0122	CbGeAlD
Pergolide—Atrial fibrillation—Riluzole—amyotrophic lateral sclerosis	0.00271	0.00352	CcSEcCtD
Pergolide—Thirst—Riluzole—amyotrophic lateral sclerosis	0.0027	0.0035	CcSEcCtD
Pergolide—HTR1D—brainstem—amyotrophic lateral sclerosis	0.00268	0.0121	CbGeAlD
Pergolide—Purpura—Riluzole—amyotrophic lateral sclerosis	0.00267	0.00346	CcSEcCtD
Pergolide—HTR2C—brainstem—amyotrophic lateral sclerosis	0.00265	0.012	CbGeAlD
Pergolide—Arthritis—Riluzole—amyotrophic lateral sclerosis	0.00265	0.00343	CcSEcCtD
Pergolide—Diplopia—Riluzole—amyotrophic lateral sclerosis	0.00257	0.00334	CcSEcCtD
Pergolide—Disturbance in sexual arousal—Riluzole—amyotrophic lateral sclerosis	0.00255	0.00331	CcSEcCtD
Pergolide—Affect lability—Riluzole—amyotrophic lateral sclerosis	0.00253	0.00328	CcSEcCtD
Pergolide—Migraine—Riluzole—amyotrophic lateral sclerosis	0.00253	0.00328	CcSEcCtD
Pergolide—Psychotic disorder—Riluzole—amyotrophic lateral sclerosis	0.00251	0.00326	CcSEcCtD
Pergolide—DRD3—nervous system—amyotrophic lateral sclerosis	0.0025	0.0113	CbGeAlD
Pergolide—Face oedema—Riluzole—amyotrophic lateral sclerosis	0.00248	0.00322	CcSEcCtD
Pergolide—Cardiac arrest—Riluzole—amyotrophic lateral sclerosis	0.00245	0.00317	CcSEcCtD
Pergolide—Urinary retention—Riluzole—amyotrophic lateral sclerosis	0.00245	0.00317	CcSEcCtD
Pergolide—Mood swings—Riluzole—amyotrophic lateral sclerosis	0.00244	0.00316	CcSEcCtD
Pergolide—Ataxia—Riluzole—amyotrophic lateral sclerosis	0.00242	0.00314	CcSEcCtD
Pergolide—DRD3—central nervous system—amyotrophic lateral sclerosis	0.0024	0.0108	CbGeAlD
Pergolide—Dehydration—Riluzole—amyotrophic lateral sclerosis	0.00239	0.0031	CcSEcCtD
Pergolide—Liver function test abnormal—Riluzole—amyotrophic lateral sclerosis	0.00237	0.00308	CcSEcCtD
Pergolide—Orthostatic hypotension—Riluzole—amyotrophic lateral sclerosis	0.00235	0.00305	CcSEcCtD
Pergolide—Hypokalaemia—Riluzole—amyotrophic lateral sclerosis	0.00234	0.00304	CcSEcCtD
Pergolide—DRD5—nervous system—amyotrophic lateral sclerosis	0.00234	0.0106	CbGeAlD
Pergolide—HTR2A—hindbrain—amyotrophic lateral sclerosis	0.00232	0.0105	CbGeAlD
Pergolide—Gastritis—Riluzole—amyotrophic lateral sclerosis	0.00228	0.00295	CcSEcCtD
Pergolide—DRD5—central nervous system—amyotrophic lateral sclerosis	0.00225	0.0102	CbGeAlD
Pergolide—Abdominal distension—Riluzole—amyotrophic lateral sclerosis	0.00224	0.0029	CcSEcCtD
Pergolide—HTR1A—brainstem—amyotrophic lateral sclerosis	0.00223	0.0101	CbGeAlD
Pergolide—Dysphagia—Riluzole—amyotrophic lateral sclerosis	0.00222	0.00288	CcSEcCtD
Pergolide—Asthma—Riluzole—amyotrophic lateral sclerosis	0.00222	0.00288	CcSEcCtD
Pergolide—Influenza—Riluzole—amyotrophic lateral sclerosis	0.00222	0.00288	CcSEcCtD
Pergolide—Pancreatitis—Riluzole—amyotrophic lateral sclerosis	0.00218	0.00283	CcSEcCtD
Pergolide—Angina pectoris—Riluzole—amyotrophic lateral sclerosis	0.00217	0.00281	CcSEcCtD
Pergolide—Bronchitis—Riluzole—amyotrophic lateral sclerosis	0.00214	0.00277	CcSEcCtD
Pergolide—CYP2D6—hindbrain—amyotrophic lateral sclerosis	0.00211	0.00953	CbGeAlD
Pergolide—Dysuria—Riluzole—amyotrophic lateral sclerosis	0.00208	0.0027	CcSEcCtD
Pergolide—ADRA1A—brainstem—amyotrophic lateral sclerosis	0.00206	0.00927	CbGeAlD
Pergolide—Pollakiuria—Riluzole—amyotrophic lateral sclerosis	0.00205	0.00266	CcSEcCtD
Pergolide—Erectile dysfunction—Riluzole—amyotrophic lateral sclerosis	0.00205	0.00266	CcSEcCtD
Pergolide—Weight increased—Riluzole—amyotrophic lateral sclerosis	0.00202	0.00262	CcSEcCtD
Pergolide—DRD2—brainstem—amyotrophic lateral sclerosis	0.00202	0.00909	CbGeAlD
Pergolide—Weight decreased—Riluzole—amyotrophic lateral sclerosis	0.00201	0.00261	CcSEcCtD
Pergolide—Pneumonia—Riluzole—amyotrophic lateral sclerosis	0.00199	0.00259	CcSEcCtD
Pergolide—Depression—Riluzole—amyotrophic lateral sclerosis	0.00198	0.00256	CcSEcCtD
Pergolide—Acute coronary syndrome—Riluzole—amyotrophic lateral sclerosis	0.00195	0.00253	CcSEcCtD
Pergolide—Myocardial infarction—Riluzole—amyotrophic lateral sclerosis	0.00194	0.00252	CcSEcCtD
Pergolide—Neuropathy peripheral—Riluzole—amyotrophic lateral sclerosis	0.00194	0.00252	CcSEcCtD
Pergolide—Jaundice—Riluzole—amyotrophic lateral sclerosis	0.00193	0.00251	CcSEcCtD
Pergolide—Urinary tract infection—Riluzole—amyotrophic lateral sclerosis	0.00193	0.0025	CcSEcCtD
Pergolide—ADRA1B—nervous system—amyotrophic lateral sclerosis	0.00192	0.00865	CbGeAlD
Pergolide—DRD3—brain—amyotrophic lateral sclerosis	0.00191	0.00861	CbGeAlD
Pergolide—Sweating—Riluzole—amyotrophic lateral sclerosis	0.0019	0.00246	CcSEcCtD
Pergolide—Haematuria—Riluzole—amyotrophic lateral sclerosis	0.00189	0.00245	CcSEcCtD
Pergolide—ADRA1D—nervous system—amyotrophic lateral sclerosis	0.00188	0.00846	CbGeAlD
Pergolide—Epistaxis—Riluzole—amyotrophic lateral sclerosis	0.00187	0.00242	CcSEcCtD
Pergolide—Sinusitis—Riluzole—amyotrophic lateral sclerosis	0.00186	0.00241	CcSEcCtD
Pergolide—HTR2C—medulla oblongata—amyotrophic lateral sclerosis	0.00185	0.00833	CbGeAlD
Pergolide—ADRA1B—central nervous system—amyotrophic lateral sclerosis	0.00185	0.00833	CbGeAlD
Pergolide—Bradycardia—Riluzole—amyotrophic lateral sclerosis	0.00181	0.00235	CcSEcCtD
Pergolide—ADRA1D—central nervous system—amyotrophic lateral sclerosis	0.00181	0.00815	CbGeAlD
Pergolide—DRD5—brain—amyotrophic lateral sclerosis	0.00179	0.00806	CbGeAlD
Pergolide—DRD1—nervous system—amyotrophic lateral sclerosis	0.00179	0.00806	CbGeAlD
Pergolide—Rhinitis—Riluzole—amyotrophic lateral sclerosis	0.00178	0.00231	CcSEcCtD
Pergolide—Hepatitis—Riluzole—amyotrophic lateral sclerosis	0.00178	0.00231	CcSEcCtD
Pergolide—Hallucination—Riluzole—amyotrophic lateral sclerosis	0.00177	0.0023	CcSEcCtD
Pergolide—Pharyngitis—Riluzole—amyotrophic lateral sclerosis	0.00177	0.00229	CcSEcCtD
Pergolide—Oedema peripheral—Riluzole—amyotrophic lateral sclerosis	0.00175	0.00227	CcSEcCtD
Pergolide—DRD1—central nervous system—amyotrophic lateral sclerosis	0.00172	0.00776	CbGeAlD
Pergolide—HTR1B—spinal cord—amyotrophic lateral sclerosis	0.00172	0.00775	CbGeAlD
Pergolide—Eye disorder—Riluzole—amyotrophic lateral sclerosis	0.00166	0.00216	CcSEcCtD
Pergolide—HTR2C—spinal cord—amyotrophic lateral sclerosis	0.00165	0.00743	CbGeAlD
Pergolide—Chills—Riluzole—amyotrophic lateral sclerosis	0.0016	0.00207	CcSEcCtD
Pergolide—Arrhythmia—Riluzole—amyotrophic lateral sclerosis	0.00159	0.00206	CcSEcCtD
Pergolide—Alopecia—Riluzole—amyotrophic lateral sclerosis	0.00157	0.00204	CcSEcCtD
Pergolide—Flatulence—Riluzole—amyotrophic lateral sclerosis	0.00153	0.00198	CcSEcCtD
Pergolide—Tension—Riluzole—amyotrophic lateral sclerosis	0.00152	0.00197	CcSEcCtD
Pergolide—Dysgeusia—Riluzole—amyotrophic lateral sclerosis	0.00152	0.00197	CcSEcCtD
Pergolide—Nervousness—Riluzole—amyotrophic lateral sclerosis	0.0015	0.00195	CcSEcCtD
Pergolide—Back pain—Riluzole—amyotrophic lateral sclerosis	0.0015	0.00194	CcSEcCtD
Pergolide—ADRA1B—brain—amyotrophic lateral sclerosis	0.00147	0.00661	CbGeAlD
Pergolide—Tremor—Riluzole—amyotrophic lateral sclerosis	0.00145	0.00188	CcSEcCtD
Pergolide—HTR2A—embryo—amyotrophic lateral sclerosis	0.00145	0.00654	CbGeAlD
Pergolide—HTR1B—nervous system—amyotrophic lateral sclerosis	0.00145	0.00653	CbGeAlD
Pergolide—Ill-defined disorder—Riluzole—amyotrophic lateral sclerosis	0.00144	0.00186	CcSEcCtD
Pergolide—ADRA1D—brain—amyotrophic lateral sclerosis	0.00143	0.00647	CbGeAlD
Pergolide—Anaemia—Riluzole—amyotrophic lateral sclerosis	0.00143	0.00186	CcSEcCtD
Pergolide—Agitation—Riluzole—amyotrophic lateral sclerosis	0.00142	0.00185	CcSEcCtD
Pergolide—HTR1D—nervous system—amyotrophic lateral sclerosis	0.0014	0.00632	CbGeAlD
Pergolide—Malaise—Riluzole—amyotrophic lateral sclerosis	0.0014	0.00181	CcSEcCtD
Pergolide—HTR1B—central nervous system—amyotrophic lateral sclerosis	0.00139	0.00629	CbGeAlD
Pergolide—Vertigo—Riluzole—amyotrophic lateral sclerosis	0.00139	0.0018	CcSEcCtD
Pergolide—Syncope—Riluzole—amyotrophic lateral sclerosis	0.00139	0.0018	CcSEcCtD
Pergolide—HTR2C—nervous system—amyotrophic lateral sclerosis	0.00139	0.00626	CbGeAlD
Pergolide—HTR1A—spinal cord—amyotrophic lateral sclerosis	0.00139	0.00626	CbGeAlD
Pergolide—Leukopenia—Riluzole—amyotrophic lateral sclerosis	0.00139	0.0018	CcSEcCtD
Pergolide—KCNH2—medulla oblongata—amyotrophic lateral sclerosis	0.00139	0.00625	CbGeAlD
Pergolide—Palpitations—Riluzole—amyotrophic lateral sclerosis	0.00137	0.00178	CcSEcCtD
Pergolide—ADRA2C—medulla oblongata—amyotrophic lateral sclerosis	0.00137	0.00616	CbGeAlD
Pergolide—DRD1—brain—amyotrophic lateral sclerosis	0.00137	0.00616	CbGeAlD
Pergolide—Loss of consciousness—Riluzole—amyotrophic lateral sclerosis	0.00136	0.00177	CcSEcCtD
Pergolide—Cough—Riluzole—amyotrophic lateral sclerosis	0.00135	0.00175	CcSEcCtD
Pergolide—HTR1D—central nervous system—amyotrophic lateral sclerosis	0.00135	0.00609	CbGeAlD
Pergolide—Convulsion—Riluzole—amyotrophic lateral sclerosis	0.00134	0.00174	CcSEcCtD
Pergolide—Hypertension—Riluzole—amyotrophic lateral sclerosis	0.00134	0.00173	CcSEcCtD
Pergolide—HTR2C—central nervous system—amyotrophic lateral sclerosis	0.00134	0.00603	CbGeAlD
Pergolide—HTR2A—brainstem—amyotrophic lateral sclerosis	0.00133	0.006	CbGeAlD
Pergolide—Arthralgia—Riluzole—amyotrophic lateral sclerosis	0.00132	0.00171	CcSEcCtD
Pergolide—Chest pain—Riluzole—amyotrophic lateral sclerosis	0.00132	0.00171	CcSEcCtD
Pergolide—Myalgia—Riluzole—amyotrophic lateral sclerosis	0.00132	0.00171	CcSEcCtD
Pergolide—Anxiety—Riluzole—amyotrophic lateral sclerosis	0.00131	0.0017	CcSEcCtD
Pergolide—HTR2B—nervous system—amyotrophic lateral sclerosis	0.0013	0.00588	CbGeAlD
Pergolide—Discomfort—Riluzole—amyotrophic lateral sclerosis	0.0013	0.00169	CcSEcCtD
Pergolide—Dry mouth—Riluzole—amyotrophic lateral sclerosis	0.00129	0.00167	CcSEcCtD
Pergolide—Confusional state—Riluzole—amyotrophic lateral sclerosis	0.00127	0.00165	CcSEcCtD
Pergolide—Oedema—Riluzole—amyotrophic lateral sclerosis	0.00126	0.00164	CcSEcCtD
Pergolide—HTR2B—central nervous system—amyotrophic lateral sclerosis	0.00126	0.00566	CbGeAlD
Pergolide—Infection—Riluzole—amyotrophic lateral sclerosis	0.00126	0.00163	CcSEcCtD
Pergolide—Shock—Riluzole—amyotrophic lateral sclerosis	0.00124	0.00161	CcSEcCtD
Pergolide—Thrombocytopenia—Riluzole—amyotrophic lateral sclerosis	0.00124	0.00161	CcSEcCtD
Pergolide—KCNH2—spinal cord—amyotrophic lateral sclerosis	0.00124	0.00557	CbGeAlD
Pergolide—Tachycardia—Riluzole—amyotrophic lateral sclerosis	0.00123	0.0016	CcSEcCtD
Pergolide—Hyperhidrosis—Riluzole—amyotrophic lateral sclerosis	0.00122	0.00158	CcSEcCtD
Pergolide—ADRA2C—spinal cord—amyotrophic lateral sclerosis	0.00122	0.0055	CbGeAlD
Pergolide—CYP2D6—brainstem—amyotrophic lateral sclerosis	0.00121	0.00546	CbGeAlD
Pergolide—Anorexia—Riluzole—amyotrophic lateral sclerosis	0.00121	0.00156	CcSEcCtD
Pergolide—Hypotension—Riluzole—amyotrophic lateral sclerosis	0.00118	0.00153	CcSEcCtD
Pergolide—HTR1A—nervous system—amyotrophic lateral sclerosis	0.00117	0.00527	CbGeAlD
Pergolide—Musculoskeletal discomfort—Riluzole—amyotrophic lateral sclerosis	0.00115	0.00149	CcSEcCtD
Pergolide—Insomnia—Riluzole—amyotrophic lateral sclerosis	0.00114	0.00148	CcSEcCtD
Pergolide—Paraesthesia—Riluzole—amyotrophic lateral sclerosis	0.00114	0.00147	CcSEcCtD
Pergolide—Dyspnoea—Riluzole—amyotrophic lateral sclerosis	0.00113	0.00146	CcSEcCtD
Pergolide—HTR1A—central nervous system—amyotrophic lateral sclerosis	0.00113	0.00508	CbGeAlD
Pergolide—Somnolence—Riluzole—amyotrophic lateral sclerosis	0.00112	0.00146	CcSEcCtD
Pergolide—Dyspepsia—Riluzole—amyotrophic lateral sclerosis	0.00111	0.00144	CcSEcCtD
Pergolide—HTR1B—brain—amyotrophic lateral sclerosis	0.00111	0.00499	CbGeAlD
Pergolide—HTR1A—cerebellum—amyotrophic lateral sclerosis	0.0011	0.00496	CbGeAlD
Pergolide—Decreased appetite—Riluzole—amyotrophic lateral sclerosis	0.0011	0.00143	CcSEcCtD
Pergolide—ADRA2A—medulla oblongata—amyotrophic lateral sclerosis	0.00109	0.00492	CbGeAlD
Pergolide—Pain—Riluzole—amyotrophic lateral sclerosis	0.00108	0.0014	CcSEcCtD
Pergolide—Constipation—Riluzole—amyotrophic lateral sclerosis	0.00108	0.0014	CcSEcCtD
Pergolide—ADRA1A—nervous system—amyotrophic lateral sclerosis	0.00108	0.00486	CbGeAlD
Pergolide—HTR1D—brain—amyotrophic lateral sclerosis	0.00107	0.00483	CbGeAlD
Pergolide—HTR2C—brain—amyotrophic lateral sclerosis	0.00106	0.00479	CbGeAlD
Pergolide—DRD2—nervous system—amyotrophic lateral sclerosis	0.00106	0.00476	CbGeAlD
Pergolide—Feeling abnormal—Riluzole—amyotrophic lateral sclerosis	0.00104	0.00135	CcSEcCtD
Pergolide—KCNH2—nervous system—amyotrophic lateral sclerosis	0.00104	0.00469	CbGeAlD
Pergolide—ADRA1A—central nervous system—amyotrophic lateral sclerosis	0.00104	0.00468	CbGeAlD
Pergolide—Gastrointestinal pain—Riluzole—amyotrophic lateral sclerosis	0.00103	0.00134	CcSEcCtD
Pergolide—ADRA2C—nervous system—amyotrophic lateral sclerosis	0.00103	0.00463	CbGeAlD
Pergolide—DRD2—central nervous system—amyotrophic lateral sclerosis	0.00102	0.00459	CbGeAlD
Pergolide—ADRA1A—cerebellum—amyotrophic lateral sclerosis	0.00101	0.00457	CbGeAlD
Pergolide—KCNH2—central nervous system—amyotrophic lateral sclerosis	0.001	0.00452	CbGeAlD
Pergolide—Body temperature increased—Riluzole—amyotrophic lateral sclerosis	0.000999	0.0013	CcSEcCtD
Pergolide—Abdominal pain—Riluzole—amyotrophic lateral sclerosis	0.000999	0.0013	CcSEcCtD
Pergolide—HTR2B—brain—amyotrophic lateral sclerosis	0.000997	0.0045	CbGeAlD
Pergolide—DRD2—cerebellum—amyotrophic lateral sclerosis	0.000994	0.00448	CbGeAlD
Pergolide—ADRA2C—central nervous system—amyotrophic lateral sclerosis	0.000989	0.00446	CbGeAlD
Pergolide—KCNH2—cerebellum—amyotrophic lateral sclerosis	0.000979	0.00442	CbGeAlD
Pergolide—ADRA2A—spinal cord—amyotrophic lateral sclerosis	0.000972	0.00438	CbGeAlD
Pergolide—ADRA2C—cerebellum—amyotrophic lateral sclerosis	0.000966	0.00436	CbGeAlD
Pergolide—HTR2A—medulla oblongata—amyotrophic lateral sclerosis	0.000927	0.00418	CbGeAlD
Pergolide—Asthenia—Riluzole—amyotrophic lateral sclerosis	0.000907	0.00118	CcSEcCtD
Pergolide—Pruritus—Riluzole—amyotrophic lateral sclerosis	0.000894	0.00116	CcSEcCtD
Pergolide—HTR1A—brain—amyotrophic lateral sclerosis	0.000893	0.00403	CbGeAlD
Pergolide—Diarrhoea—Riluzole—amyotrophic lateral sclerosis	0.000865	0.00112	CcSEcCtD
Pergolide—Dizziness—Riluzole—amyotrophic lateral sclerosis	0.000836	0.00108	CcSEcCtD
Pergolide—HTR2A—spinal cord—amyotrophic lateral sclerosis	0.000827	0.00373	CbGeAlD
Pergolide—ADRA1A—brain—amyotrophic lateral sclerosis	0.000824	0.00371	CbGeAlD
Pergolide—ADRA2A—nervous system—amyotrophic lateral sclerosis	0.000819	0.00369	CbGeAlD
Pergolide—DRD2—brain—amyotrophic lateral sclerosis	0.000807	0.00364	CbGeAlD
Pergolide—Vomiting—Riluzole—amyotrophic lateral sclerosis	0.000804	0.00104	CcSEcCtD
Pergolide—Rash—Riluzole—amyotrophic lateral sclerosis	0.000797	0.00103	CcSEcCtD
Pergolide—Dermatitis—Riluzole—amyotrophic lateral sclerosis	0.000796	0.00103	CcSEcCtD
Pergolide—KCNH2—brain—amyotrophic lateral sclerosis	0.000795	0.00359	CbGeAlD
Pergolide—Headache—Riluzole—amyotrophic lateral sclerosis	0.000792	0.00103	CcSEcCtD
Pergolide—ADRA2A—central nervous system—amyotrophic lateral sclerosis	0.000789	0.00356	CbGeAlD
Pergolide—ADRA2C—brain—amyotrophic lateral sclerosis	0.000785	0.00354	CbGeAlD
Pergolide—ADRA2A—cerebellum—amyotrophic lateral sclerosis	0.000771	0.00348	CbGeAlD
Pergolide—Nausea—Riluzole—amyotrophic lateral sclerosis	0.000751	0.000974	CcSEcCtD
Pergolide—HTR2A—nervous system—amyotrophic lateral sclerosis	0.000697	0.00314	CbGeAlD
Pergolide—HTR2A—central nervous system—amyotrophic lateral sclerosis	0.000671	0.00302	CbGeAlD
Pergolide—HTR2A—cerebellum—amyotrophic lateral sclerosis	0.000656	0.00296	CbGeAlD
Pergolide—CYP3A4—nervous system—amyotrophic lateral sclerosis	0.000645	0.00291	CbGeAlD
Pergolide—CYP2D6—nervous system—amyotrophic lateral sclerosis	0.000635	0.00286	CbGeAlD
Pergolide—ADRA2A—brain—amyotrophic lateral sclerosis	0.000626	0.00282	CbGeAlD
Pergolide—CYP3A4—central nervous system—amyotrophic lateral sclerosis	0.000621	0.0028	CbGeAlD
Pergolide—CYP2D6—central nervous system—amyotrophic lateral sclerosis	0.000611	0.00276	CbGeAlD
Pergolide—CYP2D6—cerebellum—amyotrophic lateral sclerosis	0.000597	0.00269	CbGeAlD
Pergolide—HTR2A—brain—amyotrophic lateral sclerosis	0.000532	0.0024	CbGeAlD
Pergolide—CYP2D6—brain—amyotrophic lateral sclerosis	0.000485	0.00219	CbGeAlD
Pergolide—HTR2C—Signaling by GPCR—PLA2G4A—amyotrophic lateral sclerosis	4.34e-06	0.000613	CbGpPWpGaD
Pergolide—HTR1D—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	4.29e-06	0.000606	CbGpPWpGaD
Pergolide—CYP3A4—Metabolism—SACM1L—amyotrophic lateral sclerosis	4.28e-06	0.000604	CbGpPWpGaD
Pergolide—HTR1A—GPCR downstream signaling—C3—amyotrophic lateral sclerosis	4.25e-06	0.000599	CbGpPWpGaD
Pergolide—HTR2C—GPCR downstream signaling—C3—amyotrophic lateral sclerosis	4.22e-06	0.000596	CbGpPWpGaD
Pergolide—ADRA2C—Signaling by GPCR—PLA2G4A—amyotrophic lateral sclerosis	4.22e-06	0.000596	CbGpPWpGaD
Pergolide—CYP2D6—Metabolism—PLB1—amyotrophic lateral sclerosis	4.22e-06	0.000595	CbGpPWpGaD
Pergolide—HTR1B—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	4.2e-06	0.000593	CbGpPWpGaD
Pergolide—DRD1—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	4.17e-06	0.000588	CbGpPWpGaD
Pergolide—ADRA1B—Signaling by GPCR—PLA2G4A—amyotrophic lateral sclerosis	4.15e-06	0.000586	CbGpPWpGaD
Pergolide—ADRA2A—Signaling Pathways—GFAP—amyotrophic lateral sclerosis	4.15e-06	0.000585	CbGpPWpGaD
Pergolide—HTR2B—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	4.15e-06	0.000585	CbGpPWpGaD
Pergolide—DRD4—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	4.14e-06	0.000584	CbGpPWpGaD
Pergolide—DRD3—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	4.11e-06	0.000581	CbGpPWpGaD
Pergolide—ADRA1D—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	4.11e-06	0.000581	CbGpPWpGaD
Pergolide—ADRA2C—GPCR downstream signaling—C3—amyotrophic lateral sclerosis	4.11e-06	0.00058	CbGpPWpGaD
Pergolide—ADRA2A—Signaling Pathways—C5AR1—amyotrophic lateral sclerosis	4.1e-06	0.000579	CbGpPWpGaD
Pergolide—ADRA2A—Hemostasis—IGF1—amyotrophic lateral sclerosis	4.06e-06	0.000573	CbGpPWpGaD
Pergolide—ADRA1B—GPCR downstream signaling—C3—amyotrophic lateral sclerosis	4.04e-06	0.000571	CbGpPWpGaD
Pergolide—CYP3A4—Metabolism—FIG4—amyotrophic lateral sclerosis	4.02e-06	0.000568	CbGpPWpGaD
Pergolide—ADRA2B—Signaling by GPCR—C3—amyotrophic lateral sclerosis	3.99e-06	0.000564	CbGpPWpGaD
Pergolide—DRD5—Signaling Pathways—C3—amyotrophic lateral sclerosis	3.99e-06	0.000563	CbGpPWpGaD
Pergolide—HTR2B—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	3.95e-06	0.000557	CbGpPWpGaD
Pergolide—DRD1—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	3.91e-06	0.000552	CbGpPWpGaD
Pergolide—CYP2D6—Metabolism—GSR—amyotrophic lateral sclerosis	3.89e-06	0.000549	CbGpPWpGaD
Pergolide—DRD3—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	3.86e-06	0.000544	CbGpPWpGaD
Pergolide—ADRA1D—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	3.86e-06	0.000544	CbGpPWpGaD
Pergolide—HTR1A—Signaling by GPCR—C3—amyotrophic lateral sclerosis	3.86e-06	0.000544	CbGpPWpGaD
Pergolide—HTR2C—Signaling by GPCR—C3—amyotrophic lateral sclerosis	3.84e-06	0.000541	CbGpPWpGaD
Pergolide—DRD2—Signaling by GPCR—PLA2G4A—amyotrophic lateral sclerosis	3.83e-06	0.000541	CbGpPWpGaD
Pergolide—HTR2A—Signaling by GPCR—PLA2G4A—amyotrophic lateral sclerosis	3.77e-06	0.000532	CbGpPWpGaD
Pergolide—ADRA2C—Signaling by GPCR—C3—amyotrophic lateral sclerosis	3.73e-06	0.000527	CbGpPWpGaD
Pergolide—DRD2—GPCR downstream signaling—C3—amyotrophic lateral sclerosis	3.73e-06	0.000526	CbGpPWpGaD
Pergolide—DRD1—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	3.72e-06	0.000526	CbGpPWpGaD
Pergolide—ADRA2B—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	3.71e-06	0.000524	CbGpPWpGaD
Pergolide—DRD5—Signaling Pathways—APOE—amyotrophic lateral sclerosis	3.71e-06	0.000524	CbGpPWpGaD
Pergolide—ADRA1A—Signaling by GPCR—PLA2G4A—amyotrophic lateral sclerosis	3.69e-06	0.000521	CbGpPWpGaD
Pergolide—HTR1D—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	3.67e-06	0.000519	CbGpPWpGaD
Pergolide—DRD3—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	3.67e-06	0.000519	CbGpPWpGaD
Pergolide—ADRA1D—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	3.67e-06	0.000519	CbGpPWpGaD
Pergolide—ADRA1B—Signaling by GPCR—C3—amyotrophic lateral sclerosis	3.67e-06	0.000518	CbGpPWpGaD
Pergolide—HTR2A—GPCR downstream signaling—C3—amyotrophic lateral sclerosis	3.67e-06	0.000518	CbGpPWpGaD
Pergolide—CYP3A4—Metabolism—DAO—amyotrophic lateral sclerosis	3.64e-06	0.000513	CbGpPWpGaD
Pergolide—HTR1B—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	3.6e-06	0.000508	CbGpPWpGaD
Pergolide—ADRA1A—GPCR downstream signaling—C3—amyotrophic lateral sclerosis	3.59e-06	0.000507	CbGpPWpGaD
Pergolide—HTR1A—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	3.58e-06	0.000506	CbGpPWpGaD
Pergolide—HTR2C—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	3.57e-06	0.000503	CbGpPWpGaD
Pergolide—DRD4—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	3.54e-06	0.0005	CbGpPWpGaD
Pergolide—ADRA2B—Hemostasis—VEGFA—amyotrophic lateral sclerosis	3.5e-06	0.000494	CbGpPWpGaD
Pergolide—ADRA2B—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	3.48e-06	0.000492	CbGpPWpGaD
Pergolide—ADRA2C—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	3.47e-06	0.00049	CbGpPWpGaD
Pergolide—HTR1D—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	3.45e-06	0.000488	CbGpPWpGaD
Pergolide—ADRA2A—Signaling by GPCR—PLA2G4A—amyotrophic lateral sclerosis	3.43e-06	0.000484	CbGpPWpGaD
Pergolide—ADRA1B—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	3.41e-06	0.000482	CbGpPWpGaD
Pergolide—DRD2—Signaling by GPCR—C3—amyotrophic lateral sclerosis	3.38e-06	0.000478	CbGpPWpGaD
Pergolide—HTR1B—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	3.38e-06	0.000477	CbGpPWpGaD
Pergolide—HTR2B—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	3.38e-06	0.000477	CbGpPWpGaD
Pergolide—HTR1A—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	3.36e-06	0.000475	CbGpPWpGaD
Pergolide—HTR2C—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	3.34e-06	0.000472	CbGpPWpGaD
Pergolide—ADRA2A—GPCR downstream signaling—C3—amyotrophic lateral sclerosis	3.34e-06	0.000471	CbGpPWpGaD
Pergolide—HTR2A—Signaling by GPCR—C3—amyotrophic lateral sclerosis	3.33e-06	0.00047	CbGpPWpGaD
Pergolide—DRD4—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	3.33e-06	0.00047	CbGpPWpGaD
Pergolide—ADRA2B—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	3.32e-06	0.000468	CbGpPWpGaD
Pergolide—ADRA2C—Hemostasis—VEGFA—amyotrophic lateral sclerosis	3.27e-06	0.000461	CbGpPWpGaD
Pergolide—ADRA1A—Signaling by GPCR—C3—amyotrophic lateral sclerosis	3.26e-06	0.00046	CbGpPWpGaD
Pergolide—ADRA2C—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	3.25e-06	0.000459	CbGpPWpGaD
Pergolide—ADRA2C—Metabolism—GSTP1—amyotrophic lateral sclerosis	3.25e-06	0.000458	CbGpPWpGaD
Pergolide—HTR1A—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	3.2e-06	0.000452	CbGpPWpGaD
Pergolide—ADRA1B—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	3.2e-06	0.000452	CbGpPWpGaD
Pergolide—CYP2D6—Metabolism—CHAT—amyotrophic lateral sclerosis	3.2e-06	0.000451	CbGpPWpGaD
Pergolide—DRD1—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	3.19e-06	0.00045	CbGpPWpGaD
Pergolide—HTR2C—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	3.19e-06	0.00045	CbGpPWpGaD
Pergolide—HTR2B—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	3.18e-06	0.000449	CbGpPWpGaD
Pergolide—DRD2—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	3.15e-06	0.000444	CbGpPWpGaD
Pergolide—ADRA1D—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	3.14e-06	0.000444	CbGpPWpGaD
Pergolide—DRD3—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	3.14e-06	0.000444	CbGpPWpGaD
Pergolide—ADRA2C—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	3.1e-06	0.000437	CbGpPWpGaD
Pergolide—HTR2A—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	3.1e-06	0.000437	CbGpPWpGaD
Pergolide—DRD5—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	3.07e-06	0.000433	CbGpPWpGaD
Pergolide—HTR1D—Signaling Pathways—C3—amyotrophic lateral sclerosis	3.05e-06	0.000431	CbGpPWpGaD
Pergolide—ADRA1B—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	3.05e-06	0.00043	CbGpPWpGaD
Pergolide—ADRA1A—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	3.03e-06	0.000428	CbGpPWpGaD
Pergolide—ADRA2A—Signaling by GPCR—C3—amyotrophic lateral sclerosis	3.03e-06	0.000428	CbGpPWpGaD
Pergolide—DRD1—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	3e-06	0.000423	CbGpPWpGaD
Pergolide—HTR1B—Signaling Pathways—C3—amyotrophic lateral sclerosis	2.99e-06	0.000422	CbGpPWpGaD
Pergolide—ADRA2C—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	2.98e-06	0.000421	CbGpPWpGaD
Pergolide—ADRA1D—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	2.96e-06	0.000417	CbGpPWpGaD
Pergolide—DRD3—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	2.96e-06	0.000417	CbGpPWpGaD
Pergolide—DRD2—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	2.95e-06	0.000417	CbGpPWpGaD
Pergolide—DRD4—Signaling Pathways—C3—amyotrophic lateral sclerosis	2.94e-06	0.000415	CbGpPWpGaD
Pergolide—HTR2A—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	2.9e-06	0.00041	CbGpPWpGaD
Pergolide—ADRA1A—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	2.84e-06	0.000401	CbGpPWpGaD
Pergolide—HTR1D—Signaling Pathways—APOE—amyotrophic lateral sclerosis	2.84e-06	0.000401	CbGpPWpGaD
Pergolide—ADRA2B—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	2.84e-06	0.000401	CbGpPWpGaD
Pergolide—ADRA2A—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	2.82e-06	0.000398	CbGpPWpGaD
Pergolide—DRD2—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	2.81e-06	0.000397	CbGpPWpGaD
Pergolide—HTR2B—Signaling Pathways—C3—amyotrophic lateral sclerosis	2.81e-06	0.000396	CbGpPWpGaD
Pergolide—HTR1B—Signaling Pathways—APOE—amyotrophic lateral sclerosis	2.78e-06	0.000393	CbGpPWpGaD
Pergolide—HTR2A—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	2.77e-06	0.00039	CbGpPWpGaD
Pergolide—CYP3A4—Metabolism—PLB1—amyotrophic lateral sclerosis	2.76e-06	0.000389	CbGpPWpGaD
Pergolide—HTR1A—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	2.74e-06	0.000387	CbGpPWpGaD
Pergolide—DRD4—Signaling Pathways—APOE—amyotrophic lateral sclerosis	2.74e-06	0.000387	CbGpPWpGaD
Pergolide—HTR2C—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	2.73e-06	0.000385	CbGpPWpGaD
Pergolide—ADRA1A—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	2.71e-06	0.000382	CbGpPWpGaD
Pergolide—ADRA2B—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	2.67e-06	0.000377	CbGpPWpGaD
Pergolide—ADRA2A—Hemostasis—VEGFA—amyotrophic lateral sclerosis	2.65e-06	0.000374	CbGpPWpGaD
Pergolide—ADRA2C—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	2.65e-06	0.000374	CbGpPWpGaD
Pergolide—DRD1—Signaling Pathways—C3—amyotrophic lateral sclerosis	2.65e-06	0.000374	CbGpPWpGaD
Pergolide—ADRA2A—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	2.64e-06	0.000373	CbGpPWpGaD
Pergolide—ADRA2B—Hemostasis—TP53—amyotrophic lateral sclerosis	2.64e-06	0.000373	CbGpPWpGaD
Pergolide—ADRA2A—Metabolism—GSTP1—amyotrophic lateral sclerosis	2.64e-06	0.000372	CbGpPWpGaD
Pergolide—HTR2B—Signaling Pathways—APOE—amyotrophic lateral sclerosis	2.61e-06	0.000369	CbGpPWpGaD
Pergolide—DRD3—Signaling Pathways—C3—amyotrophic lateral sclerosis	2.61e-06	0.000369	CbGpPWpGaD
Pergolide—ADRA1D—Signaling Pathways—C3—amyotrophic lateral sclerosis	2.61e-06	0.000369	CbGpPWpGaD
Pergolide—ADRA1B—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	2.61e-06	0.000368	CbGpPWpGaD
Pergolide—HTR1A—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	2.58e-06	0.000364	CbGpPWpGaD
Pergolide—HTR2C—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	2.56e-06	0.000362	CbGpPWpGaD
Pergolide—CYP3A4—Metabolism—GSR—amyotrophic lateral sclerosis	2.54e-06	0.000359	CbGpPWpGaD
Pergolide—ADRA2A—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	2.52e-06	0.000355	CbGpPWpGaD
Pergolide—ADRA2C—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	2.49e-06	0.000352	CbGpPWpGaD
Pergolide—ADRA2C—Hemostasis—TP53—amyotrophic lateral sclerosis	2.47e-06	0.000348	CbGpPWpGaD
Pergolide—DRD1—Signaling Pathways—APOE—amyotrophic lateral sclerosis	2.47e-06	0.000348	CbGpPWpGaD
Pergolide—ADRA1B—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	2.45e-06	0.000346	CbGpPWpGaD
Pergolide—ADRA2C—Metabolism—APOE—amyotrophic lateral sclerosis	2.45e-06	0.000346	CbGpPWpGaD
Pergolide—DRD3—Signaling Pathways—APOE—amyotrophic lateral sclerosis	2.43e-06	0.000343	CbGpPWpGaD
Pergolide—ADRA1D—Signaling Pathways—APOE—amyotrophic lateral sclerosis	2.43e-06	0.000343	CbGpPWpGaD
Pergolide—ADRA2A—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	2.42e-06	0.000342	CbGpPWpGaD
Pergolide—DRD2—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	2.41e-06	0.00034	CbGpPWpGaD
Pergolide—HTR2A—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	2.37e-06	0.000334	CbGpPWpGaD
Pergolide—DRD5—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	2.36e-06	0.000333	CbGpPWpGaD
Pergolide—ADRA2B—Signaling Pathways—C3—amyotrophic lateral sclerosis	2.36e-06	0.000333	CbGpPWpGaD
Pergolide—HTR1D—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	2.35e-06	0.000332	CbGpPWpGaD
Pergolide—ADRA1A—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	2.32e-06	0.000327	CbGpPWpGaD
Pergolide—HTR1B—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	2.3e-06	0.000325	CbGpPWpGaD
Pergolide—HTR1A—Signaling Pathways—C3—amyotrophic lateral sclerosis	2.28e-06	0.000321	CbGpPWpGaD
Pergolide—HTR2C—Signaling Pathways—C3—amyotrophic lateral sclerosis	2.27e-06	0.00032	CbGpPWpGaD
Pergolide—DRD4—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	2.26e-06	0.000319	CbGpPWpGaD
Pergolide—DRD2—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	2.26e-06	0.000319	CbGpPWpGaD
Pergolide—DRD5—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	2.23e-06	0.000315	CbGpPWpGaD
Pergolide—HTR2A—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	2.23e-06	0.000314	CbGpPWpGaD
Pergolide—ADRA2C—Signaling Pathways—C3—amyotrophic lateral sclerosis	2.2e-06	0.000311	CbGpPWpGaD
Pergolide—ADRA2B—Signaling Pathways—APOE—amyotrophic lateral sclerosis	2.2e-06	0.00031	CbGpPWpGaD
Pergolide—ADRA1A—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	2.18e-06	0.000308	CbGpPWpGaD
Pergolide—ADRA1B—Signaling Pathways—C3—amyotrophic lateral sclerosis	2.17e-06	0.000306	CbGpPWpGaD
Pergolide—HTR2B—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	2.16e-06	0.000305	CbGpPWpGaD
Pergolide—ADRA2A—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	2.15e-06	0.000304	CbGpPWpGaD
Pergolide—HTR1A—Signaling Pathways—APOE—amyotrophic lateral sclerosis	2.12e-06	0.000299	CbGpPWpGaD
Pergolide—HTR2C—Signaling Pathways—APOE—amyotrophic lateral sclerosis	2.11e-06	0.000298	CbGpPWpGaD
Pergolide—CYP3A4—Metabolism—CHAT—amyotrophic lateral sclerosis	2.09e-06	0.000295	CbGpPWpGaD
Pergolide—ADRA2C—Signaling Pathways—APOE—amyotrophic lateral sclerosis	2.05e-06	0.00029	CbGpPWpGaD
Pergolide—DRD1—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	2.04e-06	0.000288	CbGpPWpGaD
Pergolide—ADRA2A—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	2.03e-06	0.000286	CbGpPWpGaD
Pergolide—ADRA1B—Signaling Pathways—APOE—amyotrophic lateral sclerosis	2.02e-06	0.000285	CbGpPWpGaD
Pergolide—ADRA1D—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	2.01e-06	0.000284	CbGpPWpGaD
Pergolide—DRD3—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	2.01e-06	0.000284	CbGpPWpGaD
Pergolide—ADRA2A—Hemostasis—TP53—amyotrophic lateral sclerosis	2e-06	0.000283	CbGpPWpGaD
Pergolide—DRD5—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	2e-06	0.000283	CbGpPWpGaD
Pergolide—DRD2—Signaling Pathways—C3—amyotrophic lateral sclerosis	2e-06	0.000282	CbGpPWpGaD
Pergolide—ADRA2A—Metabolism—APOE—amyotrophic lateral sclerosis	1.99e-06	0.000281	CbGpPWpGaD
Pergolide—HTR2A—Signaling Pathways—C3—amyotrophic lateral sclerosis	1.97e-06	0.000278	CbGpPWpGaD
Pergolide—ADRA1A—Signaling Pathways—C3—amyotrophic lateral sclerosis	1.93e-06	0.000272	CbGpPWpGaD
Pergolide—DRD2—Signaling Pathways—APOE—amyotrophic lateral sclerosis	1.86e-06	0.000263	CbGpPWpGaD
Pergolide—HTR2A—Signaling Pathways—APOE—amyotrophic lateral sclerosis	1.83e-06	0.000259	CbGpPWpGaD
Pergolide—ADRA2B—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	1.81e-06	0.000256	CbGpPWpGaD
Pergolide—HTR1D—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	1.81e-06	0.000255	CbGpPWpGaD
Pergolide—ADRA1A—Signaling Pathways—APOE—amyotrophic lateral sclerosis	1.79e-06	0.000253	CbGpPWpGaD
Pergolide—ADRA2A—Signaling Pathways—C3—amyotrophic lateral sclerosis	1.79e-06	0.000253	CbGpPWpGaD
Pergolide—HTR1B—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	1.77e-06	0.00025	CbGpPWpGaD
Pergolide—HTR1A—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	1.75e-06	0.000247	CbGpPWpGaD
Pergolide—HTR2C—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	1.74e-06	0.000246	CbGpPWpGaD
Pergolide—DRD4—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	1.74e-06	0.000246	CbGpPWpGaD
Pergolide—CYP2D6—Metabolism—GSTP1—amyotrophic lateral sclerosis	1.72e-06	0.000242	CbGpPWpGaD
Pergolide—HTR1D—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	1.71e-06	0.000241	CbGpPWpGaD
Pergolide—ADRA2C—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	1.7e-06	0.000239	CbGpPWpGaD
Pergolide—ADRA2C—Metabolism—PTGS2—amyotrophic lateral sclerosis	1.68e-06	0.000237	CbGpPWpGaD
Pergolide—HTR1B—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	1.67e-06	0.000236	CbGpPWpGaD
Pergolide—ADRA1B—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	1.67e-06	0.000235	CbGpPWpGaD
Pergolide—ADRA2A—Signaling Pathways—APOE—amyotrophic lateral sclerosis	1.67e-06	0.000235	CbGpPWpGaD
Pergolide—HTR2B—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	1.66e-06	0.000235	CbGpPWpGaD
Pergolide—DRD4—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	1.65e-06	0.000232	CbGpPWpGaD
Pergolide—CYP2D6—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	1.58e-06	0.000223	CbGpPWpGaD
Pergolide—HTR2B—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	1.57e-06	0.000222	CbGpPWpGaD
Pergolide—DRD1—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	1.57e-06	0.000221	CbGpPWpGaD
Pergolide—ADRA1D—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	1.55e-06	0.000218	CbGpPWpGaD
Pergolide—DRD3—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	1.55e-06	0.000218	CbGpPWpGaD
Pergolide—DRD2—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	1.54e-06	0.000217	CbGpPWpGaD
Pergolide—HTR1D—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	1.53e-06	0.000217	CbGpPWpGaD
Pergolide—HTR2A—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	1.51e-06	0.000214	CbGpPWpGaD
Pergolide—DRD5—Signaling Pathways—TP53—amyotrophic lateral sclerosis	1.51e-06	0.000214	CbGpPWpGaD
Pergolide—HTR1B—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	1.5e-06	0.000212	CbGpPWpGaD
Pergolide—ADRA1A—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	1.48e-06	0.000209	CbGpPWpGaD
Pergolide—DRD1—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	1.48e-06	0.000209	CbGpPWpGaD
Pergolide—DRD4—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	1.48e-06	0.000209	CbGpPWpGaD
Pergolide—ADRA1D—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	1.46e-06	0.000206	CbGpPWpGaD
Pergolide—DRD3—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	1.46e-06	0.000206	CbGpPWpGaD
Pergolide—HTR2B—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	1.41e-06	0.000199	CbGpPWpGaD
Pergolide—ADRA2B—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	1.4e-06	0.000197	CbGpPWpGaD
Pergolide—ADRA2A—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	1.38e-06	0.000194	CbGpPWpGaD
Pergolide—ADRA2A—Metabolism—PTGS2—amyotrophic lateral sclerosis	1.37e-06	0.000193	CbGpPWpGaD
Pergolide—HTR1A—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	1.35e-06	0.00019	CbGpPWpGaD
Pergolide—HTR2C—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	1.34e-06	0.000189	CbGpPWpGaD
Pergolide—DRD1—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	1.33e-06	0.000188	CbGpPWpGaD
Pergolide—ADRA2B—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	1.32e-06	0.000186	CbGpPWpGaD
Pergolide—DRD3—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	1.31e-06	0.000185	CbGpPWpGaD
Pergolide—ADRA1D—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	1.31e-06	0.000185	CbGpPWpGaD
Pergolide—ADRA2C—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	1.3e-06	0.000184	CbGpPWpGaD
Pergolide—CYP2D6—Metabolism—APOE—amyotrophic lateral sclerosis	1.3e-06	0.000183	CbGpPWpGaD
Pergolide—ADRA1B—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	1.28e-06	0.000181	CbGpPWpGaD
Pergolide—HTR1A—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	1.27e-06	0.00018	CbGpPWpGaD
Pergolide—HTR2C—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	1.27e-06	0.000179	CbGpPWpGaD
Pergolide—ADRA2C—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	1.23e-06	0.000174	CbGpPWpGaD
Pergolide—ADRA1B—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	1.21e-06	0.000171	CbGpPWpGaD
Pergolide—ADRA2B—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	1.19e-06	0.000167	CbGpPWpGaD
Pergolide—DRD2—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	1.18e-06	0.000167	CbGpPWpGaD
Pergolide—HTR2A—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	1.17e-06	0.000164	CbGpPWpGaD
Pergolide—HTR1D—Signaling Pathways—TP53—amyotrophic lateral sclerosis	1.16e-06	0.000164	CbGpPWpGaD
Pergolide—HTR1A—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	1.14e-06	0.000162	CbGpPWpGaD
Pergolide—ADRA1A—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	1.14e-06	0.000161	CbGpPWpGaD
Pergolide—HTR2C—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	1.14e-06	0.000161	CbGpPWpGaD
Pergolide—HTR1B—Signaling Pathways—TP53—amyotrophic lateral sclerosis	1.14e-06	0.00016	CbGpPWpGaD
Pergolide—CYP3A4—Metabolism—GSTP1—amyotrophic lateral sclerosis	1.12e-06	0.000158	CbGpPWpGaD
Pergolide—DRD2—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	1.12e-06	0.000158	CbGpPWpGaD
Pergolide—DRD4—Signaling Pathways—TP53—amyotrophic lateral sclerosis	1.12e-06	0.000158	CbGpPWpGaD
Pergolide—ADRA2C—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	1.11e-06	0.000156	CbGpPWpGaD
Pergolide—HTR2A—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	1.1e-06	0.000155	CbGpPWpGaD
Pergolide—ADRA1B—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	1.09e-06	0.000154	CbGpPWpGaD
Pergolide—ADRA1A—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	1.08e-06	0.000152	CbGpPWpGaD
Pergolide—HTR2B—Signaling Pathways—TP53—amyotrophic lateral sclerosis	1.07e-06	0.00015	CbGpPWpGaD
Pergolide—ADRA2A—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	1.06e-06	0.00015	CbGpPWpGaD
Pergolide—CYP3A4—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	1.03e-06	0.000146	CbGpPWpGaD
Pergolide—DRD1—Signaling Pathways—TP53—amyotrophic lateral sclerosis	1.01e-06	0.000142	CbGpPWpGaD
Pergolide—DRD2—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	1e-06	0.000142	CbGpPWpGaD
Pergolide—ADRA2A—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	1e-06	0.000141	CbGpPWpGaD
Pergolide—ADRA1D—Signaling Pathways—TP53—amyotrophic lateral sclerosis	9.92e-07	0.00014	CbGpPWpGaD
Pergolide—DRD3—Signaling Pathways—TP53—amyotrophic lateral sclerosis	9.92e-07	0.00014	CbGpPWpGaD
Pergolide—HTR2A—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	9.89e-07	0.00014	CbGpPWpGaD
Pergolide—ADRA1A—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	9.68e-07	0.000137	CbGpPWpGaD
Pergolide—ADRA2A—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	8.99e-07	0.000127	CbGpPWpGaD
Pergolide—ADRA2B—Signaling Pathways—TP53—amyotrophic lateral sclerosis	8.96e-07	0.000126	CbGpPWpGaD
Pergolide—CYP2D6—Metabolism—PTGS2—amyotrophic lateral sclerosis	8.9e-07	0.000126	CbGpPWpGaD
Pergolide—HTR1A—Signaling Pathways—TP53—amyotrophic lateral sclerosis	8.65e-07	0.000122	CbGpPWpGaD
Pergolide—HTR2C—Signaling Pathways—TP53—amyotrophic lateral sclerosis	8.6e-07	0.000121	CbGpPWpGaD
Pergolide—CYP3A4—Metabolism—APOE—amyotrophic lateral sclerosis	8.49e-07	0.00012	CbGpPWpGaD
Pergolide—ADRA2C—Signaling Pathways—TP53—amyotrophic lateral sclerosis	8.37e-07	0.000118	CbGpPWpGaD
Pergolide—ADRA1B—Signaling Pathways—TP53—amyotrophic lateral sclerosis	8.23e-07	0.000116	CbGpPWpGaD
Pergolide—DRD2—Signaling Pathways—TP53—amyotrophic lateral sclerosis	7.59e-07	0.000107	CbGpPWpGaD
Pergolide—HTR2A—Signaling Pathways—TP53—amyotrophic lateral sclerosis	7.47e-07	0.000105	CbGpPWpGaD
Pergolide—ADRA1A—Signaling Pathways—TP53—amyotrophic lateral sclerosis	7.31e-07	0.000103	CbGpPWpGaD
Pergolide—ADRA2A—Signaling Pathways—TP53—amyotrophic lateral sclerosis	6.8e-07	9.59e-05	CbGpPWpGaD
Pergolide—CYP3A4—Metabolism—PTGS2—amyotrophic lateral sclerosis	5.82e-07	8.21e-05	CbGpPWpGaD
